GH1 and fatty liver disease: Dysregulation of hepatic GH signaling can lead to liver metabolic disorders, including the development of fatty liver disease and non-alcoholic steatohepatitis, with males more susceptible than females, as seen in both mice and humans (Dichtel et al., 2022; Kaltenecker et al., 2019; Oxley et al., 2023).